Juan Andres Moderna, Inc. (MRNA) insider trading activity

Juan Andres is Officer of Moderna, Inc.. Currently has a direct ownership of 12,803 shares of MRNA, which is worth approximately $526,331. The most recent transaction as insider was on Dec 28, 2022, when has been sold 2,000 shares (Common Stock) at a price of $180.0 per share, resulting in proceeds of $360,000. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 12.8K

0% 3M change

0% 12M change

Total Value Held $526,331

Juan Andres Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Dec 28 2022	SELL Open market or private sale	$360,000 $180.0 p/Share	2,000 Reduced 13.51%	12,803 Common Stock
Dec 28 2022	BUY Exercise of conversion of derivative security	$41,860 $20.93 p/Share	2,000 Added 11.9%	14,803 Common Stock
Dec 21 2022	SELL Open market or private sale	$403,400 $201.7 p/Share	2,000 Reduced 13.51%	12,803 Common Stock
Dec 21 2022	BUY Exercise of conversion of derivative security	$41,860 $20.93 p/Share	2,000 Added 11.9%	14,803 Common Stock
Dec 14 2022	SELL Open market or private sale	$390,000 $195.0 p/Share	2,000 Reduced 13.51%	12,803 Common Stock
Dec 14 2022	BUY Exercise of conversion of derivative security	$41,860 $20.93 p/Share	2,000 Added 11.9%	14,803 Common Stock
Dec 07 2022	SELL Open market or private sale	$344,320 $172.16 p/Share	2,000 Reduced 13.51%	12,803 Common Stock
Dec 07 2022	BUY Exercise of conversion of derivative security	$41,860 $20.93 p/Share	2,000 Added 11.9%	14,803 Common Stock
Nov 30 2022	SELL Open market or private sale	$347,040 $173.52 p/Share	2,000 Reduced 13.51%	12,803 Common Stock
Nov 30 2022	BUY Exercise of conversion of derivative security	$41,860 $20.93 p/Share	2,000 Added 11.9%	14,803 Common Stock
Nov 29 2022	SELL Open market or private sale	$141,473 $173.8 p/Share	814 Reduced 5.98%	12,803 Common Stock
Nov 28 2022	BUY Exercise of conversion of derivative security	-	1,808 Added 11.72%	13,617 Common Stock
Nov 23 2022	SELL Open market or private sale	$356,020 $178.01 p/Share	2,000 Reduced 14.48%	11,809 Common Stock
Nov 23 2022	BUY Exercise of conversion of derivative security	$41,860 $20.93 p/Share	2,000 Added 12.65%	13,809 Common Stock
Nov 16 2022	SELL Open market or private sale	$368,500 $184.25 p/Share	2,000 Reduced 14.48%	11,809 Common Stock
Nov 16 2022	BUY Exercise of conversion of derivative security	$41,860 $20.93 p/Share	2,000 Added 12.65%	13,809 Common Stock
Nov 10 2022	SELL Open market or private sale	$31,793 $165.59 p/Share	192 Reduced 1.6%	11,809 Common Stock
Nov 09 2022	SELL Open market or private sale	$325,000 $162.5 p/Share	2,000 Reduced 14.28%	12,001 Common Stock
Nov 09 2022	BUY Exercise of conversion of derivative security	$25,494 $10.47 p/Share	2,435 Added 14.82%	14,001 Common Stock
Nov 02 2022	SELL Open market or private sale	$308,400 $154.2 p/Share	2,000 Reduced 14.74%	11,566 Common Stock
Nov 02 2022	BUY Exercise of conversion of derivative security	$41,860 $20.93 p/Share	2,000 Added 12.85%	13,566 Common Stock
Oct 28 2022	SELL Open market or private sale	$600,000 $150.0 p/Share	4,000 Reduced 25.7%	11,566 Common Stock
Oct 28 2022	BUY Exercise of conversion of derivative security	$83,720 $20.93 p/Share	4,000 Added 20.44%	15,566 Common Stock
Aug 29 2022	SELL Open market or private sale	$113,945 $135.81 p/Share	839 Reduced 6.76%	11,566 Common Stock
Aug 26 2022	BUY Exercise of conversion of derivative security	-	1,807 Added 12.71%	12,405 Common Stock

Also insider at

AVTR

Avantor, Inc. Basic Materials

Director

EVLO

Evelo Biosciences, Inc. Healthcare

Director

Juan Andres

Officer

Cambridge, MA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells MRNA shares.

Notify only if

Value

Insider Trading

Get notified when an Moderna, Inc. insider buys or sells MRNA shares.

Notify only if

Operation

Value

Type

News

Receive news related to Moderna, Inc.

Track Activities on MRNA

Account